Clinical Trial Update: Postmarketing Study to Evaluate add-on Therapy With Anticholinergics in Patients With Overactive Bladder (OAB) on Mirabegron. [Phase 4]

View source ↗

Summary

Phase 4 postmarketing study evaluating add-on anticholinergic therapy in patients with overactive bladder who are on mirabegron; completed with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Mirabegron (mirabegron)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Overactive Bladder (OAB) | Phase 4 | Status: COMPLETED | Results posted: 2018-12-24